Zyversa Therapeutics, Inc.
WESTON, FL · Founded 2014 · CIK 0001613083 · Biotech · Public
Therapeutic molecules and drug candidates for inflammatory and renal diseases
zyversa.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $3.6M
- 7 Form D · Apr 2022
- 54 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,500,000 | |
| Private capital raised | Form D · SEC | $25,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $525,000 | |
| Private capital raised | Form D · SEC | $1,403,627 | |
| Private capital raised | Form D · SEC | $1,277,500 | |
| Private capital raised | Form D · SEC | $419,320 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1724 | Pulmocide | — | — |
| 1725 | Jaguar Gene Therapy | — | — |
| 1726 | FAUNA BIO INCORPORATED | — | — |
| 1727 | Zyversa Therapeutics, Inc. | — | $3.6M |
| 1728 | PYROJAS INC | — | — |
| 1729 | Chicago Biosolutions, Inc. | — | — |
| 1730 | DEMERX, INC. | — | $290K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Karen CashmereExecutive Officer
- Robert FinizioDirector
- Anthony GiovinazzoDirector
- Stephen GloverDirector · Executive Officer
- Aaron GreenblattDirector
- Pablo GuzmanExecutive Officer
- Andrew KimDirector
- Nick LaBellaExecutive Officer
- Jules MusingDirector
- Melda O'ConnellExecutive Officer
- Minchul ParkDirector
- Nico PronkDirector
- Eric RichmanDirector
- Shawn TitcombDirector
- Peter WolfeExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.